Paul S. Watson - Concepedia

Author

Paul S. Watson

Bristol-Myers Squibb (United States)

Also Known As

Paul S Watson, Paul S. Watson

Publications

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Inspire Institute Harvard University University of North Carolina at Chapel Hill

About

Paul S. Watson is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	576
2	Natural Sciences	8	8	730
3	Biochemistry	6	6	369
4	Engineering	3	3	119
5	Allergy	1	1	46

Paul S. Watson

Publications

959

Citations

H-Index

Page 1

	Year	Citations
A Diastereoselective Synthesis of 2,4-Disubstituted Piperidines: Scaffolds for Drug Discovery Paul S. Watson, Bin Jiang, Brian Scott Organic Letters Combinatorial ChemistryMedicinal ChemistryDiversity Oriented SynthesisNatural SciencesMedicine	2000	312
Nonconventional Stereochemical Issues in the Design of the Synthesis of the Vancomycin Antibiotics: Challenges Imposed by Axial and Nonplanar Chiral Elements in the Heptapeptide Aglycons David A. Evans, Christopher J. Dinsmore, Paul S. Watson, Angewandte Chemie International Edition Bioorganic ChemistryAntibiotic AdjuvantGlycobiologyMolecular BiologyOrganic Chemistry	1998	160
Indazoles: Regioselective Protection and Subsequent Amine Coupling Reactions David J. Slade, Nicholas F. Pelz, Wanda M. Bodnar, The Journal of Organic Chemistry DerivativesAcidic ConditionsOrganic ChemistryRegioselective Protection5-Bromoindazoles Participate	2009	82
Approaches to the Synthesis of the Vancomycin Antibiotics. Synthesis of Orienticin C (Bis-dechlorovancomycin) Aglycon David A. Evans, James C. Barrow, Paul S. Watson, Journal of the American Chemical Society Medicinal ChemistryAntimicrobial Drug DiscoveryBioorganic ChemistryBiochemistryNatural Sciences	1997	79
Addition of zinc homoenolates to acetylenic esters and amides: a formal [3 + 2] cycloaddition Michael T. Crimmins, Philippe G. Nantermet, B. Wesley Trotter, The Journal of Organic Chemistry EngineeringHeterocyclicBiochemistryAlkene MetathesisNatural Sciences	1993	50
Synthesis of the orienticin C M(2–4) macrocycle utilizing a nucleophilic aromatic substitution strategy David A. Evans, Paul S. Watson Tetrahedron Letters Bioorganic ChemistryEngineeringNatural SciencesOrganic ChemistryChemistry	1996	47
CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure–activity relationships Dean A. Wacker, Joseph B. Santella, Daniel S. Gardner, Bioorganic & Medicinal Chemistry Letters AsthmaCcr3 AntagonistsPotential New TherapyAnti-inflammatoryAllergy	2002	46
Lipophilic Modifications to Dinucleoside Polyphosphates and Nucleotides that Confer Antagonist Properties at the Platelet P2Y<sub>12</sub> Receptor James G. Douglass, Roshni I. Patel, Benjamin R. Yerxa, Journal of Medicinal Chemistry Adp-mediated Platelet AggregationPharmacotherapyConfer Antagonist PropertiesThrombosisMolecular Pharmacology	2008	38
From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: The discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis Joseph B. Santella, Daniel S. Gardner, Wenqing Yao, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryAcyclic ScaffoldsMedicineNatural Sciences	2007	30
Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists Jeffrey Varnes, Daniel S. Gardner, Joseph B. Santella, Bioorganic & Medicinal Chemistry Letters N-propylurea 3-BenzylpiperidinesBiochemistryMedicineFunctional SelectivityReceptor (Biochemistry)	2004	29

Page 1